Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01787188 · ClinicalTrials.gov registry record · Phase 3
Study of Meloxicam Capsules to Treat Osteoarthritis Pain
A Phase 3 study, sponsored by Iroko Pharmaceuticals.
- Completed
- Registry status
- Phase 3
- Development phase
- 403
- Enrollment target
NCT01787188 is a Phase 3 study that has completed, run by Iroko Pharmaceuticals. The registered enrollment target is 403 participants.
The verdict
NCT01787188, a Phase 3 study, has completed, sponsored by Iroko Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 403 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether Meloxicam \[Test\] Capsules are safe and effective for the treatment of osteoarthritis pain of the knee or hip.
Interventions
- DRUG Placebo Capsules
- DRUG Meloxicam Test Capsules
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 403 participants |
| Start Date | 2013-02 |
| Est. Completion | 2013-10 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01787188
The ClinicalTrials.gov registry entry for NCT01787188 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 403 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Iroko Pharmaceuticals, which has 12 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo Capsules is the first listed.
NCT01787188 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01787188 about?
NCT01787188 is a clinical study titled "Study of Meloxicam Capsules to Treat Osteoarthritis Pain". The purpose of this study is to determine whether Meloxicam \[Test\] Capsules are safe and effective for the treatment of osteoarthritis pain of the knee or hip.
What is the current status of trial NCT01787188?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 403 participants. The study started on 2013-02. Estimated completion is 2013-10.
What interventions are being tested in trial NCT01787188?
The interventions under investigation include: Placebo Capsules (DRUG), Meloxicam Test Capsules (DRUG).
Who is sponsoring clinical trial NCT01787188?
This trial is sponsored by Iroko Pharmaceuticals, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.